Identification of a gene signature in cell cycle pathway for breast cancer prognosis using gene expression profiling data.
BACKGROUND
Numerous studies have used microarrays to identify gene signatures for predicting cancer patient clinical outcome and responses to chemotherapy. However, the potential impact of gene expression profiling in cancer diagnosis, prognosis and development of personalized treatment may not be fully exploited due to the lack of consensus gene signatures and poor understanding of the underlying molecular mechanisms.


METHODS
We developed a novel approach to derive gene signatures for breast cancer prognosis in the context of known biological pathways. Using unsupervised methods, cancer patients were separated into distinct groups based on gene expression patterns in one of the following pathways: apoptosis, cell cycle, angiogenesis, metastasis, p53, DNA repair, and several receptor-mediated signaling pathways including chemokines, EGF, FGF, HIF, MAP kinase, JAK and NF-kappaB. The survival probabilities were then compared between the patient groups to determine if differential gene expression in a specific pathway is correlated with differential survival.


RESULTS
Our results revealed expression of cell cycle genes is strongly predictive of breast cancer outcomes. We further confirmed this observation by building a cell cycle gene signature model using supervised methods. Validated in multiple independent datasets, the cell cycle gene signature is a more accurate predictor for breast cancer clinical outcome than the previously identified Amsterdam 70-gene signature that has been developed into a FDA approved clinical test MammaPrint.


CONCLUSIONS
Taken together, the gene expression signature model we developed from well defined pathways is not only a consistently powerful prognosticator but also mechanistically linked to cancer biology. Our approach provides an alternative to the current methodology of identifying gene expression markers for cancer prognosis and drug responses using the whole genome gene expression data.
Liu
Jiangang
J
Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN 46285, USA. liu_jiangang@lilly.com
Campen
Andrew
A
Huang
Shuguang
S
Peng
Sheng-Bin
SB
Ye
Xiang
X
Palakal
Mathew
M
Dunker
A Keith
AK
Xia
Yuni
Y
Li
Shuyu
S
Anticancer Res. 2006 Nov-Dec;26(6B):4415-21
17201163
Am J Clin Pathol. 1991 Jan;95(1):41-7
1987751
Nature. 2000 Aug 17;406(6797):747-52
10963602
Nat Rev Cancer. 2008 Jan;8(1):37-49
18097463
Lancet. 2005 Feb 19-25;365(9460):671-9
15721472
Mol Med Today. 2000 Dec;6(12):459
11099949
N Engl J Med. 2007 Jan 18;356(3):294-7
17229957
J Clin Pathol. 2004 Jul;57(7):675-81
15220356
Nat Med. 2007 Nov;13(11):1276-7; author reply 1277-8
17987014
N Engl J Med. 2004 Dec 30;351(27):2817-26
15591335
Lancet Oncol. 2007 Dec;8(12):1079-1087
18042430
N Engl J Med. 2006 Aug 10;355(6):560-9
16899776
Proc Natl Acad Sci U S A. 2005 Sep 20;102(38):13550-5
16141321
Stain Technol. 1977 Jul;52(4):185-95
143737
Proc Natl Acad Sci U S A. 2005 Mar 8;102(10):3738-43
15701700
BMC Med Genomics. 2008 Apr 25;1:11
18439262
Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8418-23
12829800
Genome Biol. 2007;8(9):R187
17845722
Nature. 2006 Jan 19;439(7074):353-7
16273092
Nature. 2002 Jan 31;415(6871):530-6
11823860
Bioinformatics. 2005 Jan 15;21(2):171-8
15308542
Breast Cancer Res Treat. 2003 Nov;82(1):11-6
14672398
Ann Oncol. 2005 Nov;16(11):1723-39
15980158
J Clin Oncol. 2005 Oct 1;23(28):7212-20
16192605
Breast Cancer Res. 2005;7(6):R953-64
16280042
Proc Natl Acad Sci U S A. 2002 May 14;99(10):6567-72
12011421
N Engl J Med. 2006 Jun 8;354(23):2463-72
16760446
Cancer Sci. 2007 May;98(5):644-51
17359284
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
16199517
Nat Med. 2006 Nov;12(11):1294-300
17057710
Proc Natl Acad Sci U S A. 2007 Aug 7;104(32):13086-91
17666531
Breast Cancer Res. 2007;9(3):R33
17535433
Mol Syst Biol. 2007;3:140
17940530
Cancer Res. 1987 Sep 1;47(17):4729-35
3621170
J Pathol. 2003 Apr;199(4):424-31
12635132
Proc Natl Acad Sci U S A. 2001 Sep 11;98(19):10869-74
11553815
N Engl J Med. 2002 Nov 14;347(20):1566-75
12432043
J Proteome Res. 2003 Jul-Aug;2(4):405-12
12938930
Oncol Rep. 2004 Nov;12(5):1143-50
15492807
Mod Pathol. 1991 Nov;4(6):718-22
1724086
J Natl Cancer Inst. 2006 Sep 6;98(17):1183-92
16954471
Cancer Cell. 2004 Jun;5(6):607-16
15193263
N Engl J Med. 2002 Dec 19;347(25):1999-2009
12490681
Cytometry. 1995 Jun 15;22(2):115-27
7587742